Last edition
News about Market
iiCON Secures European Funding to Lead Pan-European Network on Infectious Disease Preparedness
iiCON will lead a Europe-wide collaboration bringing together researchers, healthcare experts, policymakers and industry partners to develop coordinated solutions for emerging infectious disease threats.
Market | 03/06/2026 | By News Bureau | 163
Alkem Brings Semaglutide Pre-Filled Syringes to Indian Market
Alkem has launched semaglutide pre-filled syringes in India, introducing a convenient single-shot administration option for the management of Type 2 Diabetes (T2D) and obesity.
Market | 03/06/2026 | By News Bureau | 187
Pfizer Launches Elranatamab in India for Relapsed or Refractory Multiple Myeloma
Pfizer has launched Elranatamab in India for adults with Relapsed or Refractory Multiple Myeloma (RRMM) who have received at least four prior therapies. The BCMA-directed bispecific antibody is available as a fixed-dose subcutaneous injection, offering a novel treatment option for heavily pretreated multiple myeloma patients.
Market | 03/06/2026 | By News Bureau | 111
Hanmi Signs Licensing Agreement with Lilly for Sonefpeglutide
Hanmi has signed a licensing agreement with Lilly for sonefpeglutide (LAPSGLP-2 analog), granting rights to develop and commercialize the investigational therapy across multiple indications.
Market | 03/06/2026 | By News Bureau | 163
Marksans Pharma Acquires Netherlands-Based QliniQ B.V. to Strengthen Europe Business
Marksans Pharma is set to acquire Netherlands-based QliniQ BV, a strategic move that expands its footprint in regulated European markets and strengthens its forward-integration strategy through direct market-access capabilities across the European Union (EU).
Market | 01/06/2026 | By News Bureau | 250
A large-scale study involving more than 6,800 lymphoma patients found that CAR T-cell therapy delivered at non-FACT accredited centres achieved outcomes comparable to accredited facilities, supporting efforts to expand access to advanced cancer treatments closer to patients’ homes.
Market | 30/05/2026 | By News Bureau | 145
SK Bioscience’s partnership with VECOL positions SK bioscience as a strategic technology transfer partner in Colombia’s national vaccine self-sufficiency initiative, supporting local manufacturing, public health preparedness and regional supply resilience.
Market | 28/05/2026 | By News Bureau | 171
Asahi Kasei Life Science Acquires License for Novel ADC Technology from The Noguchi Institute
Asahi Kasei Life Science Secures Rights to Novel Antibody Drug Conjugate (ADC) Technology from The Noguchi Institute to Advance Safer and More Efficient Cancer Therapies
Market | 28/05/2026 | By News Bureau | 153
NunaBio Raises Euro 6.5 Million to Scale Next-Generation DNA Manufacturing Platform
NunaBio’s latest funding to accelerate DNA micro-foundry development, expand manufacturing capabilities and strengthen infrastructure for synthetic biology, therapeutics, and research applications.
Market | 21/05/2026 | By News Bureau | 183
Hansa Biopharma Signs IDEFIRIX Licensing Deal with SERB Pharmaceuticals for Europe and MENA
Hansa Biopharma signs a €115 million licensing agreement with SERB Pharmaceuticals for commercialisation of IDEFIRIX across Europe and MENA, strengthening its financial position ahead of a potential US launch.
Market | 21/05/2026 | By News Bureau | 224
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy